T66M (p.Thr66Met) variant of CASQ2 (Calsequestrin-2)

T66M (p.Thr66Met) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from ClinVar and UniProt describe it as uncertain significance in the context of Catecholaminergic polymorphic ventricular tachycardia 1. The available variant effect predictions contribute to a CATVariant prioritization score of 0.17 / 1. The record also includes population frequency data and structural context.

T66M (p.Thr66Met) variant details